(S1 (S (NP (NP (JJ Metabolic) (NNS alterations)) (PP (IN in) (NP (DT a) (JJ noncachectic) (NN animal) (NN tumor) (NN system))) (. .))))
(S1 (S (S (NP (NP (DT The) (VBN increased) (NN energy)) (VP (VBN expended) (PP (IN by) (NP (NP (DT the) (NN host) (S (VP (TO to) (VP (VB synthesize) (NP (NN substrate)))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN utilized) (PP (IN by) (NP (DT the) (NN tumor))))))) (, ,))))) (VP (VBZ is) (NP (NP (DT a) (JJ potential) (NN cause)) (PP (IN of) (NP (NN cancer) (NN cachexia)))))) (. .)))
(S1 (S (S (NP (ADJP (FW In) (FW vivo)) (NP (NP (NN glucose)) (CC and) (NP (NN alanine))) (NNS kinetics)) (VP (VBD were) (VP (VBN examined) (PP (IN by) (NP (NN tracer) (NN methodology))) (PP (IN in) (NP (DT a) (JJ sarcoma-bearing) (NN rat) (NN model)))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (JJ 3-mercaptopicolinic) (NN acid)) (, ,) (NP (NP (DT a) (JJ potent) (NN inhibitor)) (PP (IN of) (NP (NN gluconeogenesis)))) (, ,)))) (VP (VBD was) (ADVP (RB also)) (VP (VBN examined) (PP (IN on) (NP (DT this) (NN model)))))) (. .)))
(S1 (S (S (S (NP (CC Both) (NP (NP (JJ tumor-bearing)) (PRN (-LRB- -LRB-) (NP (NN TB)) (-RRB- -RRB-))) (CC and) (NP (NN nontumor)) (NP (NN bearing) (-LRB- -LRB-) (NN NTB) (-RRB- -RRB-) (NNS animals))) (VP (VBD were) (NP (NN gaining) (NN weight)) (ADVP (ADVP (RB prior)) (PP (TO to) (NP (NN study)))))) (CC and) (S (NP (DT the) (NNS tumors)) (VP (VBD were) (ADJP (RB relatively) (JJ small))))) (. .)))
(S1 (S (S (NP (DT The) (JJ TB) (NNS animals)) (VP (VBD had) (NP (ADJP (RB significantly) (JJR lower)) (NP (NP (NN plasma) (NN glucose)) (CC and) (NP (JJR higher) (NN blood) (JJ lactic) (NN acid))) (NNS levels)) (PP (VBN compared) (PP (IN with) (NP (JJ NTB) (NNS animals)))))) (. .)))
(S1 (S (S (S (PP (IN After) (NP (NP (NN inhibition)) (PP (IN of) (NP (NN gluconeogenesis))))) (, ,) (NP (DT the) (NN plasma) (NN glucose)) (VP (VBD decreased))) (CC and) (S (NP (DT the) (NN blood) (NN lactate)) (VP (VBD increased) (ADVP (RB significantly) (RBR more)) (PP (IN in) (NP (NP (NNS TB)) (PP (IN than) (NP (JJ NTB) (NNS animals)))))))) (. .)))
(S1 (S (S (NP (DT The) (NN glucose) (NN turnover) (NN rate)) (VP (VBD was) (ADJP (ADJP (RB significantly) (JJR greater)) (PP (IN in) (NP (NN TB))) (PP (VBN compared) (PP (IN with) (NP (JJ NTB) (NNS animals))))) (, ,) (SBAR (IN as) (SINV (VBD was) (NP (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (NN glucose) (NN recycling)))) (CC and) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (NP (NP (NN gluconeogenesis)) (PRN (-LRB- -LRB-) (S (NP (NN alanine)) (VP (VBZ leads) (PP (TO to) (NP (NN glucose))))) (-RRB- -RRB-))) (, ,) (CC both) (NP (NN energy) (JJ demanding) (NNS processes)))))))))) (. .)))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (DT the) (JJ tumor-bearing) (NN animal)) (, ,) (PP (ADVP (RB even)) (JJ prior) (TO to) (NP (JJ significant) (NN cachexia))) (, ,) (VP (VBZ has) (NP (NP (DT an) (JJ excess) (NN demand)) (PP (IN for) (NP (NN energy))) (, ,) (SBAR (WHNP (NP (DT the) (NN provision)) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (MD may) (VP (VB be) (NP (DT a) (JJ significant) (NN factor)) (PP (IN in) (NP (JJ malignant) (NN cachexia))))))))))))) (. .)))
